[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Sanofi](/topic/sanofi)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:sanofi/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/sanofi/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +4%  
**6 Months**: XX% -X%  
**1 Year**: XX% -X%  
**1-Year High**: XX% on 2025-06-26  
**1-Year Low**: XX% on 2024-11-24  

**Most Supportive Themes**
- **Novavax Collaboration:** (35%) Positive news regarding the expansion of the collaboration and license agreement between Novavax and Sanofi, potentially boosting Sanofi's influenza vaccine program.
- **Insulin Availability:** (15%) Sanofi's initiative to make insulin medications available for $XX a month in the US is viewed positively.
- **Oversold Stocks:** (10%) Mentions of Sanofi as an oversold stock, suggesting potential for a price increase.
  
**Most Critical Themes**
- **EU Antitrust Inspection:** (10%)  An EU antitrust inspection at Sanofi's premises raises concerns about potential legal issues.
- **Multinational Exits:** (20%)  Reports of multinational companies, including those in the pharmaceutical sector, leaving Pakistan due to economic and regulatory challenges.
- **Negative Sentiment on X:** (20%)  A significant portion of engagements on X (Twitter) express negative sentiment towards Sanofi.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | X%  |
| TikTok  | XXX      | X%  | XXX     | X%  | XX       | X%  |
| YouTube | XXXXX    | XX% | XXXXX   | X%  | XXXXXX   | XX% |
| Reddit  | X        | X%  | XX      | X%  | XX       | X%  |
| News    | XX       | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXXX   | XX% |